Navigation Links
Mylan Announces Voluntary De-listing of 1.25% Senior Convertible Notes Due 2012 from Nasdaq
Date:1/5/2011

PITTSBURGH, Jan. 5, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has notified The Nasdaq Stock Market, an exchange of the NASDAQ OMX Group Inc. (Nasdaq: NDAQ), that it intends to voluntarily de-list its 1.25% Senior Convertible Notes due 2012 from the Nasdaq Capital Market, on which the notes trade under the ticker symbol "MYLNG," effective as of the open of trading on January 28, 2011. The notes will continue to trade over-the-counter (OTC) with trade data available through the Financial Industry Regulatory Authority's Trade Reporting and Compliance Engine ("TRACE"). Moving the trading of the notes from Nasdaq to the OTC market will bring the company in line with standard capital markets practice and reduce the company's regulatory burden.  

On January 5, 2011, Nasdaq notified the company that the notes did not have the number of market makers required by Nasdaq's continued listing standards. While there are multiple securities firms that regularly trade the notes, these firms do not meet the strict criteria required of a market maker under Nasdaq's listing standards. The de-listing of the notes from Nasdaq does not affect the listing or trading of the company's common stock, ticker symbol "MYL," which will continue uninterrupted on Nasdaq.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information, please visit

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Mylans Dey Pharma Partners with Meda to Market EpiPen® Auto-Injector in Europe
2. Mylan Confirms First-to-File Patent Challenge Relating to Orapred ODT®
3. Mylan Receives Approval for Generic Version of Adalat® CC Tablets
4. Mylan Announces the Conversion of its Preferred Stock into Common Stock
5. Mylan Announces Final Conversion Rate for Mandatory Convertible Preferred Stock
6. Third Circuit Denies Mylan Motion for Interim Injunction
7. Mylan Reports Adjusted Diluted EPS of $0.43; Reaffirms 2010 Adjusted Diluted EPS Guidance of $1.55 - $1.65
8. Mylan Declares Quarterly Preferred Stock Dividend
9. Mylan to Appeal Court Decision in Generic Paroxetine Hydrochloride CR Case
10. Mylan Receives Approvals for Generic Versions of Hyzaar® and Cozaar®
11. Delcath Signs Agreement With Synerx and Mylans Bioniche Teoranta for Melphalan Supply
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... NORTH CHICAGO, Ill. , Sept. 22, 2014 ... that data from several clinical studies evaluating potential ... be presented at the upcoming 2014 European Society ... in Madrid, Spain . Data ... study evaluating the safety and efficacy of veliparib ...
(Date:9/22/2014)... , Sept. 22, 2014 Arena Pharmaceuticals, Inc. (NASDAQ: ... scheduled to present a corporate overview and update at ... September 26, 2014, at 11:30 a.m. Eastern Time (8:30 ... New York City . ... available under the investor relations section of Arena,s website ...
(Date:9/22/2014)... , September 22, 2014 ... "Cell Line Development Market by Product (Equipment, Media and ... Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, ... 2019", published by MarketsandMarkets, analyzes and studies the ... Browse 114 market data tables and ...
Breaking Medicine Technology:AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 2AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 3AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 4Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 2Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 3Cell Line Development Market Worth $3.96 Billion by 2019 2Cell Line Development Market Worth $3.96 Billion by 2019 3Cell Line Development Market Worth $3.96 Billion by 2019 4
(Date:9/22/2014)... meeting in Valves and Structural Heart, the fifth annual ... the 28th to the 30th of September, 2014 at ... UK. , In the tradition of the pioneering work ... become an accepted clinical option, PCR London Valves is ... and structural heart. Through innovative technologies and their application ...
(Date:9/22/2014)... by the Cancer Science Institute of Singapore (CSI ... found that an increase in a gene known ... implicated in acute myelogenous leukaemia (AML), increasing the ... Professor Chng Wee Joo, Deputy Director and Senior ... the National University Cancer Institute, Singapore, the scientists ...
(Date:9/22/2014)... FL (PRWEB) September 22, 2014 ... than 2,000 physicians, today Clearwater Clinical ... ClearSCOPE Endoscope Adaptor for smartphones. ClearSCOPE ... video from virtually any endoscope and smartphone. , ... adaptor in response to frustrations over the cost, ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 PreDiabetes ... treatment, will work with companies to help employees learn ... development of diabetes as part of a collaboration with ... @ Work initiative. , PreDiabetes Centers Medical Director ... of Transportation in Austin on Tuesday, October 21st to ...
(Date:9/22/2014)... On Saturday, September 27, 2014, La Comunidad ... fitness fair ¡Vive tu vida! Get Up! Get Moving!® This ... better health and wellness for people of all ages and ... the public, will be held at Anson B. Nixon Park, ... 2:00 pm. , “This is a wonderful event each ...
Breaking Medicine News(10 mins):Health News:Announcing the 5th PCR London Valves, 2014 2Health News:Announcing the 5th PCR London Valves, 2014 3Health News:Announcing the 5th PCR London Valves, 2014 4Health News:Singapore researchers discover a gene that increases incidence of AML 2Health News:ClearSCOPE 2.0 Endoscope Adaptor for Smartphones Announced; Endoscopic Video Capture Reinvented 2Health News:PreDiabetes Centers to Offer Diabetes Screening at Several Companies Around Austin 2Health News:PreDiabetes Centers to Offer Diabetes Screening at Several Companies Around Austin 3Health News:La Comunidad Hispana Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:La Comunidad Hispana Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3
... -- The Human Genome Project, along with numerous parallel efforts ... fungal, and microbe genomes in the last few decades, has ... struggling to keep pace. Knowing gene sequences, after all, may ... actual manifestation of physical traits (or phenotypes) of an organism ...
... ... technical and medical market, announced today that Wiley-Blackwell has agreed to conduct a trial ... three-month trial is designed to test how SciVee products and services can supplement and ... , ...
... five cesareans due to ,failed inductions, researchers find , ... than doubles the risk of having a cesarean delivery, ... numbers to a link that experts have long suspected. ... said study author Dr. Deborah Ehrenthal, director of women,s ...
... ... a gated community on Costa Rica’s South Pacific coast – has announced it will partner ... will be dedicated to helping its residents discover health and rediscover vitality. , ... (PRWEB) June 22, 2010 -- Pegasus Star ...
... ... even sit up straight and then, one day, you,re able to run through a meadow ... the very first time when they join the Hippotherapy and Therapeutic Riding programs at CAN-TR ... and Siler City resident, Lisa Reynolds. , ...
... ... with these budget-conscious instruments. , ... (Vocus) June 22, 2010 -- Cole-Parmer introduces a new line of ... For specialists in process, production, and manufacturing facilities who count parts or add up ...
Cached Medicine News:Health News:New genetic analysis reveals principles of phenotypic expression 2Health News:Wiley-Blackwell Conducts Trial of SciVee Video Platform 2Health News:Wiley-Blackwell Conducts Trial of SciVee Video Platform 3Health News:Labor Induction May Boost C-Section Risk 2Health News:Labor Induction May Boost C-Section Risk 3Health News:Costa Rica Real Estate Project Takes a Holistic Approach to Health Care 2Health News:Costa Rica Real Estate Project Takes a Holistic Approach to Health Care 3Health News:Ponies Help Kids with Disabilities Focus on What They CAN Do 2Health News:Ponies Help Kids with Disabilities Focus on What They CAN Do 3Health News:Cole-Parmer Launches New Industrial Line of Symmetry Scales 2
... is a family of solutions that ... individuals inside hospitals, healthcare facilities, or ... The target tracking areas are networked ... of radio frequency identification (RFID) readers ...
Assetrac allows identification, location, and protection of your assets....
... The RoamAlert Integrity system builds ... ECO. All door controllers in the ... computer running a standard Windows® operating ... the use of a personal computer, ...
... uses RFID to gather patient ... departments such as surgical and ... updates of patient location to ... care events have occurred and ...
Medicine Products: